BTW, RKRW, in general since ASCO began to release abstracts to the public a few weeks in advance of the meeting (and not a handful of people like they used to), have you done any backtesting on what stocks do after the abstract release, and leading up to the meeting?
I have not, and probably should.
I am just wondering if some of my names, ariad included, selloff on the abstract data, and then gap up, if news is good, upon the actual presentation (when the media actually starts reporting on the data from the show).